Cti biopharma board
WebCompany profile page for CTI BioPharma Corp including stock price, company news, press releases, executives, board members, and contact information
Cti biopharma board
Did you know?
Web1 day ago · CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies … WebApr 11, 2024 · SEATTLE, April 10, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and …
WebCTI BioPharma is a Seattle based biopharmaceutical company focused on the development and commercialization of novel therapies that address unique unmet medical needs for patients suffering from blood-related … WebApr 10, 2024 · SEATTLE , April 10, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and …
Web1 day ago · SEATTLE, Wash., April 12, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that the management team will participate in two upcoming investor … WebMr. Metzger joined CTI BioPharma’s board in January 2024. Mr. Metzger is currently Chief Executive Officer and Member of the Board of Directors of Syndax Pharmaceuticals, …
WebSEATTLE , March 20, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and …
Web1 day ago · CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of … portable wine cabinet and barWebApr 10, 2024 · SEATTLE , April 10, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that an authorized subcommittee of the Compensation Committee of its Board of … irs eitc phone numberWebMar 6, 2024 · SEATTLE, March 6, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that an authorized subcommittee of the Compensation Committee of its Board of … irs eitc posterWebOther. $8,700. Total Compensation. $2,392,577. Board of Directors in CTI BIOPHARMA CORP. For its 2024 fiscal year, CTI BIOPHARMA CORP, listed the following board … portable wine bottle coolersWebSEATTLE , Jan. 24, 2024 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted an equity award to a new employee as an equity inducement award outside of the Company's Amended and Restated Jan 05, 2024 irs elected officialsWebKey People CTI BioPharma Corp. Board of Directors Name/Title Current Board Membership expand All Executives Adam R. Craig President, CEO, Chief Medical Officer & Director David H. Kirske... portable winzip free downloadWebMar 30, 2024 · CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted equity awards to four new … portable wine glass case